Literature DB >> 25653447

Fine mapping and characterization of the L-polymerase-binding domain of the respiratory syncytial virus phosphoprotein.

Julien Sourimant1, Marie-Anne Rameix-Welti2, Anne-Laure Gaillard3, Didier Chevret4, Marie Galloux3, Elyanne Gault5, Jean-François Eléouët6.   

Abstract

UNLABELLED: The minimum requirement for an active RNA-dependent RNA polymerase of respiratory syncytial virus (RSV) is a complex made of two viral proteins, the polymerase large protein (L) and the phosphoprotein (P). Here we have investigated the domain on P that is responsible for this critical P-L interaction. By use of recombinant proteins and serial deletions, an L binding site was mapped in the C-terminal region of P, just upstream of the N-RNA binding site. The role of this molecular recognition element of about 30 amino acid residues in the L-P interaction and RNA polymerase activity was evaluated in cellula using an RSV minigenome system and site-directed mutagenesis. The results highlighted the critical role of hydrophobic residues located in this region. IMPORTANCE: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract illness in infants. Since no vaccine and no good antivirals against RSV are available, it is essential to better understand how the viral machinery functions in order to develop new antiviral strategies. Like all negative-strand RNA viruses, RSV codes for its own machinery to replicate and transcribe its genome. The core of this machinery is composed of two proteins, the phosphoprotein (P) and the large protein (L). Here, using recombinant proteins, we have mapped and characterized the P domain responsible for this L-P interaction and the formation of an active L-P complex. These findings extend our understanding of the mechanism of action of RSV RNA polymerase and allow us to define a new target for the development of drugs against RSV.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25653447      PMCID: PMC4442346          DOI: 10.1128/JVI.03619-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Regulated but not constitutive human respiratory syncytial virus (HRSV) P protein phosphorylation is essential for oligomerization.

Authors:  A Asenjo; N Villanueva
Journal:  FEBS Lett       Date:  2000-02-11       Impact factor: 4.124

Review 2.  Protein-protein interactions as targets for antiviral chemotherapy.

Authors:  Arianna Loregian; Howard S Marsden; Giorgio Palù
Journal:  Rev Med Virol       Date:  2002 Jul-Aug       Impact factor: 6.989

3.  Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.

Authors:  L S Wyatt; B Moss; S Rozenblatt
Journal:  Virology       Date:  1995-06-20       Impact factor: 3.616

4.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

5.  Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication.

Authors:  Q Yu; R W Hardy; G W Wertz
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation-defective P mutants.

Authors:  B Mazumder; S Barik
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

7.  Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: a possible role for serine 54.

Authors:  Ana Asenjo; Lorena Rodríguez; Nieves Villanueva
Journal:  J Gen Virol       Date:  2005-04       Impact factor: 3.891

8.  The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner.

Authors:  Thi-Lan Tran; Nathalie Castagné; Virginie Dubosclard; Sylvie Noinville; Emmanuelle Koch; Mohammed Moudjou; Céline Henry; Julie Bernard; Robert Paul Yeo; Jean-François Eléouët
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

9.  The major phosphorylation sites of the respiratory syncytial virus phosphoprotein are dispensable for virus replication in vitro.

Authors:  Bin Lu; Chien-Hui Ma; Robert Brazas; Hong Jin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.

Authors:  H Grosfeld; M G Hill; P L Collins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  24 in total

1.  Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.

Authors:  Wenbin Wang; Xudong Chang; Wei Yao; Ning Wei; Na Huo; Yanhong Wang; Qiaolin Wei; Haijin Liu; Xinglong Wang; Shuxia Zhang; Zengqi Yang; Sa Xiao
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 2.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

3.  New Insights into Structural Disorder in Human Respiratory Syncytial Virus Phosphoprotein and Implications for Binding of Protein Partners.

Authors:  Nelson Pereira; Christophe Cardone; Safa Lassoued; Marie Galloux; Jenna Fix; Nadine Assrir; Ewen Lescop; François Bontems; Jean-François Eléouët; Christina Sizun
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

4.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

5.  HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases.

Authors:  Louis-Marie Bloyet; Jérémy Welsch; François Enchery; Cyrille Mathieu; Sylvain de Breyne; Branka Horvat; Boyan Grigorov; Denis Gerlier
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

6.  Functional correlations of respiratory syncytial virus proteins to intrinsic disorder.

Authors:  Jillian N Whelan; Krishna D Reddy; Vladimir N Uversky; Michael N Teng
Journal:  Mol Biosyst       Date:  2016-04-26

7.  RNA elongation by respiratory syncytial virus polymerase is calibrated by conserved region V.

Authors:  Molly R Braun; Laure R Deflubé; Sarah L Noton; Michael E Mawhorter; Chadene Z Tremaglio; Rachel Fearns
Journal:  PLoS Pathog       Date:  2017-12-27       Impact factor: 6.823

8.  Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase.

Authors:  Paul C Jordan; Cheng Liu; Pauline Raynaud; Michael K Lo; Christina F Spiropoulou; Julian A Symons; Leo Beigelman; Jerome Deval
Journal:  PLoS Pathog       Date:  2018-02-09       Impact factor: 6.823

9.  Mechanism for de novo initiation at two sites in the respiratory syncytial virus promoter.

Authors:  Tessa N Cressey; Sarah L Noton; Kartikeya Nagendra; Molly R Braun; Rachel Fearns
Journal:  Nucleic Acids Res       Date:  2018-07-27       Impact factor: 16.971

10.  Structural dissection of human metapneumovirus phosphoprotein using small angle x-ray scattering.

Authors:  Max Renner; Guido C Paesen; Claire M Grison; Sébastien Granier; Jonathan M Grimes; Cédric Leyrat
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.